News Boston Scientific Corporation

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:00:02 20/05/2026 BST			After hours 01:00:00
56.67 ^USD	-0.25%		57.05	+0.67%

05-19	Leerink Partners Adjusts Boston Scientific PT to $87 From $86, Maintains Outperform Rating	MT
05-19	Boston Scientific Catheter Says Trial Meets Safety, Effectiveness Goals	MT

All News

Mentions Relevance

05-19	Leerink Partners Adjusts Boston Scientific PT to $87 From $86, Maintains Outperform Rating	MT
05-19	Boston Scientific Catheter Says Trial Meets Safety, Effectiveness Goals	MT
05-19	Fracture IDE trial of the Boston Scientific SEISMIQ 4CE coronary intravascular lithotripsy catheter meets primary safety and effectiveness endpoints	RE
05-19	Baird Adjusts Price Target on Boston Scientific to $75 From $78, Maintains Outperform Rating	MT
05-19	FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints	PR
05-19	Boston Scientific Corporation Announces Positive Results from Pivotal Fracture Ide Trial of Seismiq 4Ce Coronary Intravascular Lithotripsy Catheter	CI
05-18	Sector Update: Healthcare Stocks Advance Late Afternoon	MT
05-18	Boston Scientific Makes Third Attempt at TAVR Market, Needham Says	MT
05-18	BofA Securities Adjusts Boston Scientific Price Target to $68 From $105	MT
05-18	Boston Scientific Sets $2 Billion Accelerated Stock Buyback	DJ
05-18	Boston Scientific Enters $2 Billion Accelerated Share Repurchase Agreement With JPMorgan	MT
05-18	Boston Scientific invests $1.5 billion in MiRus with option to buy heart-valve business	RE
05-18	Boston Scientific enters into $2 billion accelerated share repurchase agreement	RE
05-18	Boston Scientific Buys 34% Stake in MiRus for $1.5 Billion	DJ
05-18	Boston Scientific enters into $2 billion accelerated share repurchase agreement	PR
05-18	Boston Scientific Invests $1.5 Billion in MiRus	MT
05-18	Boston Scientific announces strategic investment in MiRus	RE
05-18	Boston Scientific announces strategic investment in MiRus LLC	PR
05-08	Fda Expands Recall of Boston Scientific Cardiac Resynchronization Therapy Devices Following Software Update Advisory	CI
05-08	FDA Issues Most Serious Recall for Certain Pacemaker Devices by Boston Scientific	CI
05-08	FDA Issues Recall for Multiple Boston Scientific Pacemakers Over Software Advisory Expansion	CI
05-07	Boston Scientific to Update Pacemakers in Recall, FDA Says	DJ
05-07	US FDA issues recall of Boston Scientific heart devices	RE
05-06	Penumbra, Inc. Reports First Quarter 2026 Financial Results	PR
05-04	Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results	PR